Trial intelligence / Profile preview

Liraglutide adjunctive therapy in poorly controlled type 1 diabetes

2012-001150-26Phase 4Completed

Sponsor: Steno Diabetes Center
Start: May 2012
Modality: Peptides
Countries: 1

Overview

Phase 4, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing Liraglutide + insulin with Placebo + insulin (2 arms). Primary endpoint: Change in HbA1c. Started May 2012; status: completed.

Drugs

liraglutide

Conditions

diabetes mellitus type 1 (T1D)

Beyond the preview

Go deeper on 2012-001150-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-001150-26.